Molecular insights into NF2/Merlin tumor suppressor function

FEBS Letters

Volumn 588, Issue 16, 2014, Pages 2743-2752

  Cooper, Jonathan ^a   Giancotti, Filippo G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Contact inhibition; CRL4 E3 ubiquitin ligase; DDB1 and Cul4 Associated Factor 1; Hippo signaling pathway; Merlin; Neurofibromatosis Type 2

Indexed keywords

ALPHA CATENIN; ANGIOMOTIN; CRL4 DDB1 AND CUL4 ASSOCIATED FACTOR 1; CYTOPLASM PROTEIN; DDB1 AND CUL4 ASSOCIATED FACTOR 1; EZRIN; HERMES ANTIGEN; MEMBRANE PROTEIN; MERLIN; MOESIN; NHERF PROTEIN; RADIXIN; TAP PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; YAP PROTEIN;

CELL MEMBRANE; CONVERGENT EVOLUTION; CYTOSKELETON; ENZYME INACTIVATION; ENZYME INHIBITION; HIPPO SIGNALING; NF2 GENE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; SUMOYLATION; TUMOR SUPPRESSOR GENE; UBIQUITINATION;

CONTACT INHIBITION; CRL4 E3 UBIQUITIN LIGASE; DDB1 AND CUL4-ASSOCIATED FACTOR 1; HIPPO SIGNALING PATHWAY; MERLIN; NEUROFIBROMATOSIS TYPE 2;

ANIMALS; HUMANS; NEOPLASMS; NEUROFIBROMIN 2; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT;

EID: 84905098209     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.04.001     Document Type: Review

References (131)

1. A.I. McClatchey, and A.S. Yap Contact inhibition (of proliferation) redux Curr. Opin. Cell Biol. 24 2012 685 694
2. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
3. G.A. Rouleau et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 Nature 363 1993 515 521
4. J. Trofatter et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor Cell 75 1993 826
5. D. Lallemand, M. Curto, I. Saotome, M. Giovannini, and A.I. McClatchey NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions Genes Dev. 17 2003 1090 1100
6. H. Morrison et al. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44 Genes Dev. 15 2001 968 980
7. T. Okada, M. Lopez-Lago, and F.G. Giancotti Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane J. Cell Biol. 171 2005 361 371
8. J.Q. Cheng, W.C. Lee, M.A. Klein, G.Z. Cheng, S.C. Jhanwar, and J.R. Testa Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation Genes Chromosomes Cancer 24 1999 238 242
9. M. Bott et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma Nat. Genet. 43 2011 668 672
10. A.B. Bianchi et al. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types Nat. Genet. 6 1994 185 192
11. G.L. Dalgliesh et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes Nature 463 2010 360 363
12. Y.K. Lau, L.B. Murray, S.S. Houshmandi, Y. Xu, D.H. Gutmann, and Q. Yu Merlin is a potent inhibitor of glioma growth Cancer Res. 68 2008 5733 5742
13. A.K. Rustgi, L. Xu, D. Pinney, C. Sterner, R. Beauchamp, S. Schmidt, J.F. Gusella, and V. Ramesh Neurofibromatosis 2 gene in human colorectal cancer Cancer Genet. Cytogenet. 84 1995 24 26
14. A.I. McClatchey, and R.G. Fehon Merlin and the ERM proteins - regulators of receptor distribution and signaling at the cell cortex Trends Cell Biol. 19 2009 198 206
15. K. Kaempchen, K. Mielke, T. Utermark, S. Langmesser, and C.O. Hanemann Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells Hum. Mol. Genet. 12 2003 1211 1221
16. J.L. Kissil, E.W. Wilker, K.C. Johnson, M.S. Eckman, M.B. Yaffe, and T. Jacks Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1 Mol. Cell 12 2003 841 849
17. R.J. Shaw et al. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling Dev. Cell 1 2001 63 72
18. M.F. James, S. Han, C. Polizzano, S.R. Plotkin, B.D. Manning, A.O. Stemmer-Rachamimov, J.F. Gusella, and V. Ramesh NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth Mol. Cell Biol. 29 2009 4250 4261
19. M.A. Lopez-Lago, T. Okada, M.M. Murillo, N. Socci, and F.G. Giancotti Loss of the tumor suppressor gene NF2, encoding merlin, constitutively activates integrin-dependent mTORC1 signaling Mol. Cell Biol. 29 2009 4235 4249
20. R. Rong, X. Tang, D.H. Gutmann, and K. Ye Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L Proc. Natl. Acad. Sci. U.S.A. 101 2004 18200 18205
21. P.I. Poulikakos, G.H. Xiao, R. Gallagher, S. Jablonski, S.C. Jhanwar, and J.R. Testa Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK Oncogene 25 2006 5960 5968
22. H. Jin, T. Sperka, P. Herrlich, and H. Morrison Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase Nature 442 2006 576 579
23. S. Ammoun, C. Flaiz, N. Ristic, J. Schuldt, and C.O. Hanemann Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma Cancer Res. 68 2008 5236 5245
24. N. Zhang et al. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals Dev. Cell 19 2010 27 38
25. F. Hamaratoglu, M. Willecke, M. Kango-Singh, R. Nolo, E. Hyun, C. Tao, H. Jafar-Nejad, and G. Halder The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis Nat. Cell Biol. 8 2006 27 36
26. B. Zhao et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control Genes Dev. 21 2007 2747 2761
27. I. Sher, C.O. Hanemann, P.A. Karplus, and A. Bretscher The tumor suppressor merlin controls growth in its open state, and phosphorylation converts it to a less-active more-closed state Dev. Cell 22 2012 703 705
28. C. Yi et al. A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions Cancer Cell 19 2011 527 540
29. W. Li et al. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus Cell 140 2010 477 490
30. L. Sherman, H. Xu, R. Geist, S. Saporito-Irwin, N. Howells, H. Ponta, P. Herrlich, and D. Gutmann Interdomain binding mediates tumor growth suppression by the NF2 gene product Oncogene 15 1997 2505 2509
31. C. Gonzalez-Agosti, T. Wiederhold, M.E. Herndon, J. Gusella, and V. Ramesh Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF J. Biol. Chem. 274 1999 34438 34442
32. D. Lallemand, A.L. Saint-Amaux, and M. Giovannini Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells J. Cell Sci. 122 2009 4141 4149
33. A. Bretscher, K. Edwards, and R.G. Fehon ERM proteins and merlin: integrators at the cell cortex Nat. Rev. Mol. Cell Biol. 3 2002 586 599
34. T. Shimizu, A. Seto, N. Maita, K. Hamada, S. Tsukita, and T. Hakoshima Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain J. Biol. Chem. 277 2002 10332 10336
35. K.C. Johnson, J.L. Kissil, J.L. Fry, and T. Jacks Cellular transformation by a FERM domain mutant of the Nf2 tumor suppressor gene Oncogene 21 2002 5990 5997
36. D.R. LaJeunesse, B.M. McCartney, and R.G. Fehon Structural analysis of Drosophila merlin reveals functional domains important for growth control and subcellular localization J. Cell Biol. 141 1998 1589 1599
37. R. Gary, and A. Bretscher Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site Mol. Biol. Cell 6 1995 1061 1075
38. Q. Li, M.R. Nance, R. Kulikauskas, K. Nyberg, R. Fehon, P.A. Karplus, A. Bretscher, and J.J. Tesmer Self-masking in an intact ERM-merlin protein: an active role for the central alpha-helical domain J. Mol. Biol. 365 2007 1446 1459
39. M.A. Pearson, D. Reczek, A. Bretscher, and P.A. Karplus Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain Cell 101 2000 259 270
40. L. Heiska, K. Alfthan, M. Grönholm, P. Vilja, A. Vaheri, and O. Carpén Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4,5-bisphosphate J. Biol. Chem. 273 1998 21893 21900
41. S. Tsukita, K. Oishi, N. Sato, J. Sagara, and A. Kawai ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons J. Cell Biol. 126 1994 391 401
42. R. Nguyen, D. Reczek, and A. Bretscher Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP J. Biol. Chem. 276 2001 7621 7629
43. D.H. Gutmann, C.A. Haipek, and K. Hoang Lu Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations J. Neurosci. Res. 58 1999 706 716
44. J.J. Meng et al. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin J. Neurosci. Res. 62 2000 491 502
45. R. Rong, E.I. Surace, C.A. Haipek, D.H. Gutmann, and K. Ye Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression Oncogene 23 2004 8447 8454
46. E.I. Surace, C.A. Haipek, and D.H. Gutmann Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function Oncogene 23 2004 580 587
47. R.F. Hennigan, L.A. Foster, M.F. Chaiken, T. Mani, M.M. Gomes, A.B. Herr, and W. Ip Fluorescence resonance energy transfer analysis of merlin conformational changes Mol. Cell Biol. 30 2010 54 67
48. I. Ahronowitz, W. Xin, R. Kiely, K. Sims, M. MacCollin, and F.P. Nunes Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings Hum. Mutat. 28 2007 1 12
49. J.L. Kissil, K.C. Johnson, M.S. Eckman, and T. Jacks Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization J. Biol. Chem. 277 2002 10394 10399
50. I. Serrano, P.C. McDonald, F. Lock, W.J. Muller, and S. Dedhar Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase Nat. Commun. 4 2013 2976
51. R. Shaw et al. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling Dev. Cell 1 2001 63 72
52. R.J. Shaw, A.I. McClatchey, and T. Jacks Regulation of the neurofibromatosis type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli J. Biol. Chem. 273 1998 7757 7764
53. M. Laulajainen, T. Muranen, O. Carpen, and M. Gronholm Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton Oncogene 27 2008 3233 3243
54. K. Alfthan, L. Heiska, M. Gronholm, G.H. Renkema, and O. Carpen Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization J. Biol. Chem. 279 2004 18559 18566
55. H.A. Kim, J.E. DeClue, and N. Ratner CAMP-dependent protein kinase A is required for Schwann cell growth: interactions between the cAMP and neuregulin/tyrosine kinase pathways J. Neurosci. Res. 49 1997 236 247
56. X. Tang et al. Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation Nat. Cell Biol. 9 2007 1199 1207
57. Q. Qi, X. Liu, D.J. Brat, and K. Ye Merlin sumoylation is required for its tumor suppressor activity Oncogene 2013
58. A.I. McClatchey, and M. Giovannini Membrane organization and tumorigenesis - the NF2 tumor suppressor, Merlin Genes Dev. 19 2005 2265 2277
59. A.B. Gladden, A.M. Hebert, E.E. Schneeberger, and A.I. McClatchey The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex Dev. Cell 19 2010 727 739
60. M. Sainio et al. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton J. Cell Sci. 110 Pt 18 1997 2249 2260
61. B.M. McCartney, and R.G. Fehon Distinct cellular and subcellular patterns of expression imply distinct functions for the Drosophila homologues of moesin and the neurofibromatosis 2 tumor suppressor, merlin J. Cell Biol. 133 1996 843 852
62. R.J. Shaw, A.I. McClatchey, and T. Jacks Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin Cell Growth Differ. 9 1998 287 296
63. C. Gonzalez-Agosti, L. Xu, D. Pinney, R. Beauchamp, W. Hobbs, J. Gusella, and V. Ramesh The merlin tumor suppressor localizes preferentially in membrane ruffles Oncogene 13 1996 1239 1247
64. S. Scherer, and D. Gutmann Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells J. Neurosci. Res. 46 1996 595 605
65. A. Murthy, C. Gonzalez-Agosti, E. Cordero, D. Pinney, C. Candia, F. Solomon, J. Gusella, and V. Ramesh NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins J. Biol. Chem. 273 1998 1273 1276
66. K. Schlegelmilch et al. Yap1 acts downstream of alpha-catenin to control epidermal proliferation Cell 144 2011 782 795
67. M.R. Silvis et al. Alpha-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1 Sci. Signal. 4 2011 ra33
68. S.H. Choi, C. Estarás, J.J. Moresco, J.R. Yates, and K.A. Jones α-Catenin interacts with APC to regulate β-catenin proteolysis and transcriptional repression of Wnt target genes Genes Dev. 27 2013 2473 2488
69. C.D. Wells et al. A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells Cell 125 2006 535 548
70. M. Ernkvist et al. The Amot/Patj/Syx signaling complex spatially controls RhoA GTPase activity in migrating endothelial cells Blood 113 2009 244 253
71. J.T. Stickney, W.C. Bacon, M. Rojas, N. Ratner, and W. Ip Activation of the tumor suppressor merlin modulates its interaction with lipid rafts Cancer Res. 64 2004 2717 2724
72. T. Mani, R.F. Hennigan, L.A. Foster, D.G. Conrady, A.B. Herr, and W. Ip FERM domain phosphoinositide binding targets merlin to the membrane and is essential for its growth-suppressive function Mol. Cell Biol. 31 2011 1983 1996
73. M. Okada, Y. Wang, S.W. Jang, X. Tang, L.M. Neri, and K. Ye Akt phosphorylation of merlin enhances its binding to phosphatidylinositols and inhibits the tumor-suppressive activities of merlin Cancer Res. 69 2009 4043 4051
74. E. Brault, A. Gautreau, M. Lamarine, I. Callebaut, G. Thomas, and L. Goutebroze Normal membrane localization and actin association of the NF2 tumor suppressor protein are dependent on folding of its N-terminal domain J. Cell Sci. 114 2001 1901 1912
75. L.B. Bensenor, K. Barlan, S.E. Rice, R.G. Fehon, and V.I. Gelfand Microtubule-mediated transport of the tumor-suppressor protein Merlin and its mutants Proc. Natl. Acad. Sci. U.S.A. 107 2010 7311 7316
76. H.M. Xu, and D.H. Gutmann Merlin differentially associates with the microtubule and actin cytoskeleton J. Neurosci. Res. 51 1998 403 415
77. Z. Smole, C.R. Thoma, K.T. Applegate, M. Duda, K.L. Gutbrodt, G. Danuser, and W. Krek Tumor suppressor NF2/Merlin is a microtubule stabilizer Cancer Res. 74 2014 353 362
78. R.F. Hennigan, C.A. Moon, L.M. Parysek, K.R. Monk, G. Morfini, S. Berth, S. Brady, and N. Ratner The NF2 tumor suppressor regulates microtubule-based vesicle trafficking via a novel Rac, MLK and p38(SAPK) pathway Oncogene 32 2013 1135 1143
79. T. Muranen, M. Gronholm, G.H. Renkema, and O. Carpen Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin Oncogene 24 2005 1150 1158
80. M. Kressel, and B. Schmucker Nucleocytoplasmic transfer of the NF2 tumor suppressor protein merlin is regulated by exon 2 and a CRM1-dependent nuclear export signal in exon 15 Hum. Mol. Genet. 11 2002 2269 2278
81. S. Zhang, Y. Feng, O. Narayan, and L.J. Zhao Cytoplasmic retention of HIV-1 regulatory protein Vpr by protein-protein interaction with a novel human cytoplasmic protein VprBP Gene 263 2001 131 140
82. L.J. Zhao, S. Mukherjee, and O. Narayan Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein J. Biol. Chem. 269 1994 15577 15582
83. S. Angers, T. Li, X. Yi, M.J. MacCoss, R.T. Moon, and N. Zheng Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery Nature 443 2006 590 593
84. K. Hrecka, M. Gierszewska, S. Srivastava, L. Kozaczkiewicz, S. Swanson, L. Florens, M. Washburn, and J. Skowronski Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle Proc. Natl. Acad. Sci. U.S.A. 104 2007 11778 11783
85. E. Le Rouzic, N. Belaidouni, E. Estrabaud, M. Morel, J.C. Rain, C. Transy, and F. Margottin-Goguet HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase Cell Cycle 6 2007 182 188
86. T. Li, E.I. Robert, P.C. van Breugel, M. Strubin, and N. Zheng A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery Nat. Struct. Mol. Biol. 17 2010 105 111
87. J. Andrejeva, E. Poole, D.F. Young, S. Goodbourn, and R.E. Randall The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5 J. Virol. 76 2002 11379 11386
88. T. Li, X. Chen, K.C. Garbutt, P. Zhou, and N. Zheng Structure of DDB1 in complex with a paramyxovirus V protein: viral hijack of a propeller cluster in ubiquitin ligase Cell 124 2006 105 117
89. M.D. Petroski, and R.J. Deshaies Function and regulation of cullin-RING ubiquitin ligases Nat. Rev. Mol. Cell Biol. 6 2005 9 20
90. N. Laguette et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx Nature 474 2011 654 657
91. K. Hrecka et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein Nature 474 2011 658 661
92. E.S. Lim, O.I. Fregoso, C.O. McCoy, F.A. Matsen, H.S. Malik, and M. Emerman The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx Cell Host Microbe 11 2012 194 204
93. J. Ahn, C. Hao, J. Yan, M. DeLucia, J. Mehrens, C. Wang, A. Gronenborn, and J. Skowronski HIV/simian immunodeficiency virus (SIV) accessory virulence factor Vpx loads the host cell restriction factor SAMHD1 onto the E3 ubiquitin ligase complex CRL4DCAF1 J. Biol. Chem. 287 2012 12550 12558
94. B. Descours et al. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells Retrovirology 9 2012 87
95. H.M. Baldauf et al. SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells Nat. Med. 18 2012 1682 1687
96. D. Schwefel, H.C. Groom, V.C. Boucherit, E. Christodoulou, P.A. Walker, J.P. Stoye, K.N. Bishop, and I.A. Taylor Structural basis of lentiviral subversion of a cellular protein degradation pathway Nature 505 2014 234 238
97. J. Lee et al. EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex Mol. Cell 48 2012 572 586
98. K. Kim et al. VprBP has intrinsic kinase activity targeting histone H2A and represses gene transcription Mol. Cell 52 2013 459 467
99. J. Ahn, T. Vu, Z. Novince, J. Guerrero-Santoro, V. Rapic-Otrin, and A.M. Gronenborn HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation J. Biol. Chem. 285 2010 37333 37341
100. N. Laguette et al. Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing Cell 156 2014 134 145
101. Y. Tamori et al. Involvement of Lgl and Mahjong/VprBP in cell competition PLoS Biol. 8 2010 e1000422
102. M.D. Kassmeier et al. VprBP binds full-length RAG1 and is required for B-cell development and V(D)J recombination fidelity EMBO J. 31 2012 945 958
103. M. Kaur, M. Khan, A. Kar, A. Sharma, and S. Saxena CRL4-DDB1-VPRBP ubiquitin ligase mediates the stress triggered proteolysis of Mcm10 Nucleic Acids Res. 40 2012 7332 7346
104. K. Kim, K. Heo, J. Choi, S. Jackson, H. Kim, Y. Xiong, and W. An Vpr-binding protein antagonizes p53-mediated transcription via direct interaction with H3 tail Mol. Cell Biol. 32 2012 783 796
105. C. Yu et al. CRL4 complex regulates mammalian oocyte survival and reprogramming by activation of TET proteins Science 342 2013 1518 1521
106. L. Tan, and Y.G. Shi Tet family proteins and 5-hydroxymethylcytosine in development and disease Development 139 2012 1895 1902
107. I. Conlon, and M. Raff Size control in animal development Cell 96 1999 235 244
108. A.C. Lloyd The regulation of cell size Cell 154 2013 1194 1205
109. D. Pan The hippo signaling pathway in development and cancer Dev. Cell 19 2010 491 505
110. B. Zhao, K. Tumaneng, and K.L. Guan The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal Nat. Cell Biol. 13 2011 877 883
111. D. Zhou et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene Cancer Cell 16 2009 425 438
112. K.P. Lee et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis Proc. Natl. Acad. Sci. U.S.A. 107 2010 8248 8253
113. L. Lu et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver Proc. Natl. Acad. Sci. U.S.A. 107 2010 1437 1442
114. H. Song et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression Proc. Natl. Acad. Sci. U.S.A. 107 2010 1431 1436
115. R. Johnson, and G. Halder The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment Nat. Rev. Drug Discovery 13 2014 63 79
116. C.L. Chen, K.M. Gajewski, F. Hamaratoglu, W. Bossuyt, L. Sansores-Garcia, C. Tao, and G. Halder The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila Proc. Natl. Acad. Sci. U.S.A. 107 2010 15810 15815
117. J. Yu, Y. Zheng, J. Dong, S. Klusza, W.M. Deng, and D. Pan Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded Dev. Cell 18 2010 288 299
118. K. Harvey, and N. Tapon The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network Nat. Rev. Cancer 7 2007 182 191
119. F.A. Grusche, H.E. Richardson, and K.F. Harvey Upstream regulation of the hippo size control pathway Curr. Biol. 20 2010 R574 R582
120. S. Saburi et al. Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease Nat. Genet. 40 2008 1010 1015
121. Y. Mao et al. Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian development Development 138 2011 947 957
122. S. Visser-Grieve, Y. Hao, and X. Yang Human homolog of Drosophila expanded, hEx, functions as a putative tumor suppressor in human cancer cell lines independently of the Hippo pathway Oncogene 31 2012 1189 1195
123. W. Bossuyt, C.L. Chen, Q. Chen, M. Sudol, H. McNeill, D. Pan, A. Kopp, and G. Halder An evolutionary shift in the regulation of the Hippo pathway between mice and flies Oncogene 33 2014 1218 1228
124. S.W. Chan, C.J. Lim, Y.F. Chong, A.V. Pobbati, C. Huang, and W. Hong Hippo pathway-independent restriction of TAZ and YAP by angiomotin J. Biol. Chem. 286 2011 7018 7026
125. M. Paramasivam, A. Sarkeshik, J.R. Yates, M.J. Fernandes, and D. McCollum Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor Mol. Biol. Cell 22 2011 3725 3733
126. W. Wang, J. Huang, and J. Chen Angiomotin-like proteins associate with and negatively regulate YAP1 J. Biol. Chem. 286 2011 4364 4370
127. B. Zhao, L. Li, Q. Lu, L.H. Wang, C.Y. Liu, Q. Lei, and K.L. Guan Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein Genes Dev. 25 2011 51 63
128. C. Yi et al. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis Sci. Signal. 6 2013 ra77
129. F. Yin, J. Yu, Y. Zheng, Q. Chen, N. Zhang, and D. Pan Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2 Cell 154 2013 1342 1355
130. Li, W. et al. Merlin/NF2-loss driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway components Lats1 and 2 in the nucleus, Cancer Cell, in press.
131. O. Shalem et al. Genome-scale CRISPR-Cas9 knockout screening in human cells Science 343 2014 84 87